Director/Senior Director, Medical Physics (EU based)
ARTBIO
Sales & Business Development
Basel, Switzerland
Posted on Saturday, June 29, 2024
Summary
The Director of Medical Physics will be expected to take on a highly visible role with internal and external stakeholders through development of the strategy and management of medical physics and imaging for clinical protocols in ARTBIO’s Radioligand Therapy (RLT) clinical development programs. As a critical member of the Program Team, the Director of Medical Physics will work closely with program leads, functional heads and subject matter experts to advance the company’s development pipeline.
The position can be based in any of our locations: Boston / London / Oslo / Basel.
Responsibilities
ARTBIO is a clinical-stage radiopharmaceutical company redefining cancer care by creating a new class of alpha radioligand therapies (ARTs). The unique ARTBIO approach selects the optimal alpha-precursor isotope (212Pb) and tumor-specific targets to create therapeutics with the potential for highest efficacy and safety. The company's AlphaDirect™ technology, a first-of-its-kind 212Pb isolation method, enables a distributed manufacturing approach for the reliable production and delivery of ARTs. ARTBIO is advancing multiple pipeline programs with lead program AB001 currently in first in human trials. ARTBIO is shaped by a long-standing scientific legacy with nearly a century of pioneering work in radiation therapy conducted at the University of Oslo and Norway’s Radium Hospital. For more information, visit www.artbio.com, and follow us on LinkedIn and Twitter.
As an emerging, global biotech with locations in Boston, Massachusetts, Basel, Switzerland, London, England and Oslo, Norway, we take advantage of diverse scientific depth and insights which makes ARTBIO a unique place to work. We are driven by a desire to do better for cancer patients, lowering the burden of toleration and safety while at the same time raising the bar on clinical efficacy and duration.
EEO Statement
ARTBIO is proud to be an equal opportunity workplace and is an affirmative action employer. We are committed to equal employment opportunity regardless of race, color, ancestry, religion, sex, national origin, sexual orientation, age, citizenship, marital status, disability, gender identity or Veteran status. If you have a disability or special need that requires accommodation, please let us know.
The Director of Medical Physics will be expected to take on a highly visible role with internal and external stakeholders through development of the strategy and management of medical physics and imaging for clinical protocols in ARTBIO’s Radioligand Therapy (RLT) clinical development programs. As a critical member of the Program Team, the Director of Medical Physics will work closely with program leads, functional heads and subject matter experts to advance the company’s development pipeline.
The position can be based in any of our locations: Boston / London / Oslo / Basel.
Responsibilities
- Develop strategies designed to support the clinical development plans for RLT agents
- As a key member of the clinical team, contributes to the design and development of protocols, plans and procedures required for RLT clinical studies for both radiotherapeutics and imaging agents. Implements protocols for treatment of patients with radioactive materials
- Provides oversight and guidance for Medical Physics, Imaging and Radiation Protection for clinical trials
- Delivers subject matter expertise regarding Medical Physics, including advanced imaging techniques (PET/CT, SPECT, etc), dosimetry estimation, and radiation protection
- Manages the resolution of technical/medical physics/dosimetry questions and issues on a study and program level
- Develops procedures and guidance to minimize radiation exposure to patients and clinical site personnel
- Leads imaging/dosimetry academic collaborations, contractors, vendor/partner interactions
- Oversees CRO vendors including imaging core labs and dosimetry vendors to ensure they optimally execute clinical imaging projects
- As a member of the oncology clinical team, ensures strong collaboration between functions, collaborators, and vendors and high team performance
- Participates in program development/enhancement, financial planning and analysis, metric and reporting, shared services relationship management, contract compliance, and process improvement
- At least 12 years of industry experience; advanced degree required, Ph.D. preferred, in Medical Physics or Radiation Protection
- Demonstrate a strong technical understanding of and commitment to medical imaging and dosimetry in the field of RLT development
- Experience of Medical Imaging, Regulatory and Clinical Research processes
- Direct experience designing and managing imaging aspects of clinical protocols for oncology RLT agents (including study design, endpoint selection, dosimetry, harmonization between clinical sites, imaging core lab oversight, etc.)
- Specific experience with imaging study design and direct/indirect estimation of normal organ and tumour dosimetry for early-stage clinical development in RLT agents
- Interpersonal skills, organization and communication skills, leadership skills and problem-solving competency
- Demonstrated ability to work well under pressure
- Strong organizational, planning, and time management skills
- Demonstrated ability to work well with team members and independently
- Commitment to continuous learning and staying updated on industry trends and advancement
ARTBIO is a clinical-stage radiopharmaceutical company redefining cancer care by creating a new class of alpha radioligand therapies (ARTs). The unique ARTBIO approach selects the optimal alpha-precursor isotope (212Pb) and tumor-specific targets to create therapeutics with the potential for highest efficacy and safety. The company's AlphaDirect™ technology, a first-of-its-kind 212Pb isolation method, enables a distributed manufacturing approach for the reliable production and delivery of ARTs. ARTBIO is advancing multiple pipeline programs with lead program AB001 currently in first in human trials. ARTBIO is shaped by a long-standing scientific legacy with nearly a century of pioneering work in radiation therapy conducted at the University of Oslo and Norway’s Radium Hospital. For more information, visit www.artbio.com, and follow us on LinkedIn and Twitter.
As an emerging, global biotech with locations in Boston, Massachusetts, Basel, Switzerland, London, England and Oslo, Norway, we take advantage of diverse scientific depth and insights which makes ARTBIO a unique place to work. We are driven by a desire to do better for cancer patients, lowering the burden of toleration and safety while at the same time raising the bar on clinical efficacy and duration.
EEO Statement
ARTBIO is proud to be an equal opportunity workplace and is an affirmative action employer. We are committed to equal employment opportunity regardless of race, color, ancestry, religion, sex, national origin, sexual orientation, age, citizenship, marital status, disability, gender identity or Veteran status. If you have a disability or special need that requires accommodation, please let us know.